Elevated levels of manganese in the blood are associated with an increased risk for specific head and neck cancers, including oral cavity squamous cell carcinoma and human papillomavirus-positive oropharyngeal cancer, according to a study published in JAMA Otolaryngology–Head & Neck Surgery.
Investigating Genetic Predispositions and Blood Manganese Levels
Previous epidemiologic research pointed to a connection between elevated trace metals in the bloodstream and a higher risk of developing oral malignancies. However, those earlier observations often carried limiting biases that complicated clear causal links. To address this, investigators deployed a two-sample cis-mendelian randomization study designed to test whether a person’s genetic predisposition toward higher blood manganese levels translates to a measurable risk for squamous cell carcinomas in distinct anatomical sites.
The study pooled data from 6,564 Scandinavian participants. By drawing on a meta-analysis of three individual-level genome-wide association study datasets, researchers identified specific gene variants that reliably predicted blood manganese levels in that population. They then cross-referenced those genetic markers against a much larger pool of clinical data.
Scope of the Clinical Data and Cancer Subtypes Analyzed
The analysis incorporated records from 38,857 control participants alongside thousands of confirmed case patients diagnosed with distinct forms of head and neck cancer. Specifically, the evaluated cohorts included 5,596 case patients with oral cavity squamous cell carcinoma (OCSCC), 2,212 case patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC), and 1,473 case patients with HPV-negative OPSCC. The team also examined 898 case patients with hypopharyngeal squamous cell carcinoma (HPSCC) and 4,409 case patients with laryngeal squamous cell carcinoma (LSCC).
By determining whether gene variants known to raise manganese levels appeared more frequently among cancer patients than control participants, the team measured disease risk as an odds ratio for each increase of one standard deviation in blood manganese.
Statistically Significant Associations Found in Specific Sites
The analysis revealed a clear statistical link for two specific cancer subtypes. Elevated blood manganese showed a significant association with a higher risk for oral cavity squamous cell carcinoma, registering an odds ratio of 1.25 with a 95% confidence interval spanning 1.10 to 1.43 and a p-value of less than 0.001. A similar significant risk elevation appeared in HPV-positive oropharyngeal squamous cell carcinoma, showing an odds ratio of 1.23, a 95% confidence interval from 1.04 to 1.45, and a p-value of 0.02.
By contrast, the associations for other evaluated sites did not reach statistical significance. HPV-negative oropharyngeal squamous cell carcinoma showed an odds ratio of 1.20 with a 95% confidence interval from 0.95 to 1.50 and a p-value of 0.13. Hypopharyngeal squamous cell carcinoma yielded an odds ratio of 1.25 with a 95% confidence interval of 0.75 to 2.07 and a p-value of 0.39. Laryngeal squamous cell carcinoma recorded an odds ratio of 1.10 with a 95% confidence interval spanning 0.92 to 1.32 and a p-value of 0.28.
Broader Body Climate Frameworks in Cancer Research
The investigation into trace metals like manganese intersects with broader systemic frameworks examining how the internal body environment influences oncogenesis. Modern oncology increasingly views cancer as a systemic disease involving interactions across the entire organism and its internal milieu, rather than a purely isolated cellular process driven strictly by random mutations.
Broader scientific models propose that internal body climates can either promote or inhibit cancer initiation and progression. While traditional mutation-based frameworks focus on driver mutations and evolutionary views examine clonal selection and drug resistance, systemic approaches emphasize that systemic imbalances may affect tumor susceptibility across different tissues.
Next Steps and Future Research Directions
The findings from the Scandinavian cohort analysis raise important questions regarding the precise biological mechanisms through which manganese influences head and neck cancer development. Investigators indicate that future research must determine the underlying pathophysiological mechanisms driving these associations.
Uncovering how trace metals interact with cellular tissues could eventually inform targeted strategies for cancer prevention. As researchers work to identify specific systemic factors that alter tissue vulnerability, studies like this provide genetic evidence connecting trace metal levels to specific malignancies.
